Literature DB >> 1574952

Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women.

G Pioli1, M Pedrazzoni, E Palummeri, M Sianesi, R Del Frate, P P Vescovi, M Prisco, V Ulietti, D Costi, M Passeri.   

Abstract

The effects of suppressive doses of L-thyroxine on the appendicular and axial bone mineral content were followed for 12-36 months after total or subtotal thyroidectomy in 15 premenopausal women. Compared to age-matched controls, these patients had a more marked bone loss of the spinal bone mineral content (2.6 +/- 1.9% vs 0.2 +/- 1.2% per year). The changes in radial cortical bone density were not significantly different from the control group. We conclude that when a suppressive therapy with L-thyroxine is necessary the rate of bone loss should be monitored at regular intervals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1574952     DOI: 10.1530/acta.0.1260238

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  6 in total

Review 1.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

2.  Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.

Authors:  María Luisa De Mingo Dominguez; Sonsoles Guadalix Iglesias; Cristina Martin-Arriscado Arroba; Begoña López Alvarez; Guillermo Martínez Diaz-Guerra; Jose Ignacio Martinez-Pueyo; Eduardo Ferrero Herrero; Federico Hawkins Carranza
Journal:  Endocrine       Date:  2018-07-16       Impact factor: 3.633

3.  Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer.

Authors:  Mi Young Lee; Jae Hyun Park; Keum Seok Bae; Yong Gwan Jee; An Na Ko; Yong Jea Han; Jang Yel Shin; Jung Soo Lim; Choon Hee Chung; Seong Joon Kang
Journal:  Ann Surg Treat Res       Date:  2014-01-22       Impact factor: 1.859

Review 4.  Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.

Authors:  Maria Papaleontiou; Sarah T Hawley; Megan R Haymart
Journal:  Oncologist       Date:  2015-12-09

Review 5.  Bone disease in thyrotoxicosis.

Authors:  P Amaresh Reddy; C V Harinarayan; Alok Sachan; V Suresh; G Rajagopal
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

Review 6.  Is calcitonin an important physiological substance?

Authors:  Philip F Hirsch; Hans Baruch
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.